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ABSTRACT 
Objectives: The purpose of the present study is to assess the reliability and validity of IPSS in 
pre- and treatment of Sudanese patients with BPH. 
Material and methods: In a descriptive prospective study, 350 Sudanese patients with LUTS 
attended the Urology department of Gezira Hospital for Renal Diseases and Surgery from 
September 2003 to April 2006. They were interviewed by urologists and answered the 
International Prostate Symptom Score (IPSS) questionnaire. Clinical work up was done for all 
only patients with benign hyperplasia were included in the analysis .Europeans guideline was 
adopted in the management and the out come was also subjected to IPSS evaluation. 
Results: The most common voiding symptoms was a weak stream (93% of subjects), followed 
by intermittency (57%) and hesitancy (54%). The most prevalence of storage symptoms was 
nocturia (87% of subjects), followed by frequency (73%) and urgency (64%). 
64% of the study subjects   presented with severe IPSS, 33% with moderate IPSS, while only 
3% of the patients presented with mild IPSS. Digital rectal examination  
(DRE) was done to all study subjects. There was no significant correlation between DRE and 
IPSS reported. 
The postoperative IPSS post treatment follow up was mild in 87%, moderate in 4% and sever 
in 9% of the patients. 
 
Conclusion: Our study indicates that IPSS is informative and reproducible in assessment of 
patients with BPH.   
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Introduction:   
Lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) 
is a common condition, and age-specific prevalence rates range between 50 and 85% among 
men >50 years of age (1). The International Prostate Symptom Score (IPSS) is a clinical 
parameter that has been commonly used in the multicenter, international clinical trials to assess 
this medical problem.  
The IPSS has become the international standard. It is derived form the American 
Urological Association (AUA) 7 score derived by Barry and his colleagues in the early 1990s 
(2). By adding the scores (with equal weighting) to its constituent questions, a summary of 
index score is generated which has been shown to an accurate reflection of a man’s overall 
symptoms over the proceeding month (3). The extent to which the self reported scores reflect 
actual events has been questioned. Men report nocturia with accuracy but tend to overstate 
daytime frequency. Correlation of self-reported score to intermittency or to the strength of 
stream was poor (4). IPSS developed by the World Health Organization (WHO) has been 
widely used in assessing LUTS in many countries both in community-based and in clinical-
based studies.  
The seven-item IPSS (along with one question relating to disease-specific quality of 
life) is easy to administer, simple, short and only requires 10–15 min for completion by 
respondents (5). In addition, evaluating symptom severity with a symptom score is an 
important part of the initial assessment of a man. 
The aim of this study is to assess the reliability and validity of IPSS in pre- and post-
treatment Sudanese patients with BPH.   
Materials and Methods: 
This was an analytic, prospective study. Patients who attended the Urology department 
of Gezira Hospital for Renal Diseases and Surgery from September 2003 to April 2006 were 
included in this study. It is worth noting that this is the only fully specialized hospital dealing 
solely with urology and nephrology and therefore it shoulders the largest serve from various 
catchments areas .Adult patients presenting with Lower Urinary Tract Infection (LUTI) and 
who are being investigated for lower urinary tract symptoms (LUTS) secondary to Benign 
Prostate Hyperplasia (BPH) were included in the study. Patients with prostate cancer, with 
urethral stricture, with spinal cord injury and those underwent surgical operation or hormonal 
therapies were excluded. A total of 350 men with symptomatic BPH their age between 55 - 97 
years (mean age 67.3 years) gave their written informed consent to participate in the study after 
the nature and the purpose of the study were explained to them, the study was approved by the 
ethical committee. The following data were recorded: age at recruitment, geographical 
localization, residence, marital status, and main complains (voiding symptoms, storage 
symptoms).  
The urinary symptoms studied were frequency, nocturia, urgency, intermittency, weak 
stream, incomplete emptying and straining. Each subject was assessed by a trained registrar, 
medical officer and supervised by a consultant urologist to evaluate the severity of urinary 
symptoms using the International Prostate Symptoms Score (IPSS) for BPH (6). A score of 1 
or more defined a subject to have that particular symptom except for nocturia, which was 
scored as 2 or more. Based on correlations between the symptom index and other scores, three 
subclasses of patients were categorized according to the  total score results: those with mild 
(IPSS 0–7), moderate (IPSS 8–19), and severe (IPSS 20–35) symptoms. BPH was diagnosed 
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when the prostate specific antigen was normal and/or the biopsy result was normal, maximum 
flow less than 15 ml/s and prostate size was greater than 30 g. The following the criteria of the 
EAU road map for management of BPH was adopted. All patients with mild IPSS were 
classified for watchful waiting including advisory planet of fluid intake and abandoning 
decongestants and regular screening for transient urinary infection which may necessitate early 
management. Patients with moderate IPSS without absolute indication for surgery were 
categorized for drugs therapy including Doxasocin alpha blockers (Cardura) and\or 5 alpha 
reductase inhibitor finaestride generally we combined them both to have the best results. 
Patients with severe IPSS or recurrent UTI, hydroureter, hydronephrosis, renal impairment, 
and haematuria or stone disease with consideration of patient consent were scheduled for 
surgical intervention. The selection of TURP was chosen   depending upon the size limit of 
45gm, fibrous prostate, medial lobe disease and \or just tunneling in post open surgery 
recurrence   .All postoperative complications were diagnosed and dealt with them appropriately 
and all patients were followed for 6 months. The association between the IPSS, BPH index and 
other clinical investigation were assessed using spearman rank correlation. 
Results: 
           A total of 350 respondents were participated in this study. The demographic data for the 
study subjects were reported in (Table 1). Concerning the age of our patients, most of them 
(more than 70% were at the age between 60 – 80 years), with slight rarity at age less than 50 
years. The most common voiding symptoms was weak stream (93% of subjects), followed by 
intermittency (57%), hesitancy (54%), incomplete evacuation (44%), straining (44%), 
dribbling of urine (43%) (Figure 1). The most prevalent storage symptoms was nocturia (87% 
of subjects), followed by frequency (73%), urgency (64%), dysuria (54%), strangury (35%), 
urge incontinence (28%) (Figure 2). 
 Overflow incontinence were found in(19%), and haematuria in (13%) . On applying 
the symptoms 64% of the study subjects  presented with severe IPSS, 33% with moderate IPSS, 
while only 3% of the patients presented with mild IPSS. DRE was done to all study subjects. 
Around  68% were with prostate weighed more than 50 gram. There was no significant 
correlation between DRE and IPSS (Table 2). Urthrocystoscopy was done to the patients when 
indicated according to the European guide line and we categorized the patients three groups; 
moderate sign of BOO (37%), mild (11%) and severe (52%) depending on the patterns of 
mucosa, muscles and residual volume (Table 3). U/S was done for  all  patients to evaluate the 
prostate parameters and upper urinary tract and other abdominal pathology. 
As shown in table 1, the postoperative IPSS in late follow up was mild in 87%, 
moderate in 4% and sever in 9% of the patients. Surgery was done for 79 patients, who included 
almost all the patients with severe IPSS, the postoperative complication were shown in (Table 
3). 
 
 
 
 
 
 
 
Table 1. Characteristics of study subjects admitted to the clinic 
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Characteristic  Persons at risk (n=350) 
Age (yr) 
40-49 
50-59 
60-69 
70-79 
80-89 
90-99 
 
 1.4 % 
 11.1 % 
 38.5 % 
 36.2 % 
 8.8 % 
 4.0 % 
Residence 
Central Sudan 
Eastern Sudan 
Western Sudan  
 
229 pts 
67   pts 
54   pts 
Marital status 
Single 
Married 
 
7     pts 
343  pts 
Pre-operative IPSS 
Mild (0-7) 
Moderate (8-19) 
Severe (20-35) 
 
3% 
33% 
64% 
Post-operative IPSS 
Mild (0-7) 
Moderate (8-19) 
Severe (20-35) 
 
87% 
4% 
9% 
Types of management 
Watch full 
Drugs 
Surgery   
 
4% 
17% 
79% 
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Table 2. Correlation between DRE and IPSS in Sudanese patients with BPH 
 
Weight  IPSS Correlation 
Mild Moderate Severe 
Weight <50g (count) 
 
2% 
 
11% 
 
19% 
 
 
0.07 (NS) 
Weight >50g (count) 
 
 
1% 
 
 
22% 
 
 
45% 
 
 
 
0.02 (NS) 
TOTAL 
 
3% 33% 64% 100% 
NS = not significant 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Cytoscopic finding and pos-operative complication in study subjects. 
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Findings Frequency 
Cytoscopic finding: 
Mild BOO 
Moderate BOO 
Severe BOO 
Urethral stricture &Vesical stone 
 
37% 
11% 
52% 
12% 
Post-operative complications: 
Wound infection 
Dribbling of urine 
Incontinence 
Retention 
Leakage 
Retrograde ejaculation 
Impotence 
Bleeding 
Death  
 
6.5% 
5.5% 
2.8% 
0.7% 
2.0% 
13.5% 
13.0 % 
2.0% 
0.5% 
 
 
Discussion: 
BPH is the most common disease affecting men of all ethnicities who are older than 40 
years of age. Increasing evidence has shown that the prevalence and natural history of BPH may 
differ in ethnic groups. The large variation in existing prevalence depends on BPH definitions, 
assessments and geographic region. Prostatectomy is the most common form of major surgery in 
men >55 years of age in the United States (7, 8). In this study, we observed a linear association 
with age. It is currently estimated that a 40-years-old man who lived to the age of 80 would have 
one chance in three of having a prostatectomy for BPH if current surgery rates prevailed (7, 8)   
Because there is not yet sufficient consensus on the definition of BPH, epidemiological 
studies attempting to define the prevalence of the disease must include data on symptoms, urinary 
flow, and prostate size of all study subjects. In this study we attempted to evaluate the 
questionnaire-based IPSS in Sudanese patients with BPH. Their age ranged between 60-80 years. 
We found that, the prevalence of moderate (33%) to severe (64%) symptoms of BPH according to 
IPSS was higher than most of the previous studies (9-11). Possible reasons for the different 
prevalence for BPH are the sample size, the cultural factors such as acceptance or non-acceptance 
of urinary symptoms as a natural part of aging, the active or inactive life styles of the elderly men. 
The problem of Arabic version of IPSS translation was not really a problem, since we tried to 
introduce it in the nearest meaning akin to the patients' knowledge and accent. The other possible 
explanation is that, Sudanese people might falsely believe that agreeing with a doctor offer them 
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good services or at the other hand they were not usually in strict concentration to answer specific 
question. 
In this study, nocturia, frequency and urgency were the common storage symptoms, which 
were found to be the most bothersome BPH related symptoms (12). Urgency and urge incontinence 
were found in 64% and 28% respectively. These two symptoms were annoying our patients 
because they considered it as social stigma, most of them would never volunteer to tell it 
spontaneously. It is well established that patients with BPH and renal insufficiency have an 
increase risk of postoperative complication being 25% for patients with renal condition (13).   
In this study, 70% of the study subjects underwent surgical operation. Post-operative IPSS 
dramatically changed to very low percentage of severity compared with the data before operation. 
However, the post operative complications reported was 6.5% as wound infection  all treated with 
dressing and they did well, urinary incontinence or dribbling of urine after surgery in 5.5% cases. 
most of pts with this symptoms treated in the first month, 0.7% pts re admitted as a result of post 
open  surgery retention, underwent other session of TURP and they did well, 7 cases of urinary 
leakage due to either catheter blockage or early stricture treated accordingly. Yet the complications 
were within the endorsed literature. 
Conclusion, 
 IPSS was found to be informative, reproducible in assessment of patients with BPH. 
However there are certain limitations like the lack of IPSS Arabic version, communicability of 
Sudanese patients is not peculiarly distinctive to estimate the answer of the questions precisely, 
and the poor compliance of patients to treatment makes the assessment more difficult. Despite all 
the difficulties and sample size as well, IPSS was found to be easy for classification of patients 
and it yielded gratifying results and post treatment improvement. 
 
REFERENCES 
1- Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the 
autopsy prevalence of benign prostatic hyperplasia. Prostate 1990; 17: 241–6. 
2- Laguna P, Alivizatos G. Prostate specific antigen and benign prostatic hyperplasia. Curr Opin Urol 
2000; 10: 3-8. 
3- Easthman JA, Sartor O, Richey W, Moparty B, Sullivan J. Racial variation in prostate specific 
antigen in a large cohort of men without prostate cancer. J La State Med Soc 2001; 153: 184-189. 
4- Cooney KA, Strawderman MS, Wojno KJ, Doerr KM, Taylor A, Alcser KH, Heeringa SG, Taylor 
JM, Wei JT, Montie JE, Schottenfeld D. Age-specific distribution of serum prostate-specific 
antigen in a community-based study of African-American men. Urology. 2001; 57(1): 91-6. 
5- Barry MJ, Fowler FJ Jr, O’Leary MP et al. The American Urological Association symptom index 
for benign prostatic hyperplasia. Measurement Committee Ameri- can Urological Association. J. 
Urol. 1992; 148: 1549–57. 
6- Barry MJ, Williford WO, Chang Y et al (1995) Benign prostatic hyperplasia specific health status 
measures in clinical research: how much change in the American Urological Association symptom 
index and the benign prostatic hyperplasi impact index is perceptible to patients? J Urol 154:1770–
1774.  
7- Napalkov P, Maisonneuve P, Boyle P (1995) Geographical and temporal patterns of incidence and 
mortality from prostate cancer. Urology 46:47–55  
8- Stephenson WP, Chute CG, Guess HA et al (1991) Incidence and outcome of surgery for benign 
prostatic hyperplasia among residents of Rochester, Minnesota: 1980–87. A population-based 
study. Urology 38:32–42  
 EDITORIAL  
 
Gezira Journal Of Health Sciences 2001 vol.6(2)  
 
Gezira Journal of Health Sciences 2001 vol.6 (2) 
9- Chute CG, Panser LA, Girman CJ et al (1993) The prevalence of prostatism: a population-based 
survey of urinary symptoms. J Urol 150:85–89  
10- Tsukamoto T, Kumamoto Y, Masumori N et al (1995) Prevalence of prostatism in Japanese men 
in a communitybased study with comparison to a similar American study. J Urol 154:391–395  
11- Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez- Cruz JJ et al (1998) Prevalence of benign 
prostatic hyperplasia in Spanish men 40 years old or older. J Urol 159:878–882. 
12- Patrick C Walsh. Benign prostatic hyperplasia. In: Campbell’s Urology, 7th edition. Philadelphia, 
W.B. Saunders, 1988, pp. 1009-1025. 
13- Mc Connell J. BPH treatment guideline and patient classification. BJU, 1995; 76 (Suppl 1): 29-46. 
 
